Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Posts 64 Percent Rise in Fiscal Q2 Revenue as Icoria Ag Line Winds Down and Erases Profits

NEW YORK (GenomeWeb News) — Clinical Data today said fiscal second-quarter 2007 revenues increased 64 percent as R&D spending on vilazodone studies rose 54 percent and profit turned swung to a loss.
 
Total receipts for the three months ended Sept. 30 increased to $19.2 million from $11.7 million year over year.
 
Clinical Data said revenues slid back $4 million from the previous quarter in 2006, however, because of the “final wind down” of subsidiary Icoria’s agricultural line. Clinical Data acquired Icoria in January for $11 million.
 
R&D spending on the company’s Vilazadone study increased to $2 million from
$1.3 million year over year.
 
Clinical Data posted a $8.1-million net loss from a $377,000 profit in the year-ago period.
 
The company said it paid $1.4 million in the second quarter in restructuring charges due to acquisition-related costs.  
 
Clinical Data said it had around $16.8 million in cash and cash equivalents as of Sept. 30.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.